IL96407A0 - Diazine derivatives - Google Patents
Diazine derivativesInfo
- Publication number
- IL96407A0 IL96407A0 IL96407A IL9640790A IL96407A0 IL 96407 A0 IL96407 A0 IL 96407A0 IL 96407 A IL96407 A IL 96407A IL 9640790 A IL9640790 A IL 9640790A IL 96407 A0 IL96407 A0 IL 96407A0
- Authority
- IL
- Israel
- Prior art keywords
- novel compounds
- compounds
- diazine derivatives
- hypertension
- manufacture
- Prior art date
Links
- 125000005331 diazinyl group Chemical class N1=NC(=CC=C1)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Insulating Materials (AREA)
- Vibration Prevention Devices (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898926211A GB8926211D0 (en) | 1989-11-20 | 1989-11-20 | Diazine derivatives |
| GB909011348A GB9011348D0 (en) | 1990-05-21 | 1990-05-21 | Nitrogen heterocycles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL96407A0 true IL96407A0 (en) | 1991-08-16 |
Family
ID=26296233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL96407A IL96407A0 (en) | 1989-11-20 | 1990-11-19 | Diazine derivatives |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5126344A (pt) |
| EP (1) | EP0454831B1 (pt) |
| JP (1) | JPH04505161A (pt) |
| KR (1) | KR920701206A (pt) |
| AT (1) | ATE109481T1 (pt) |
| AU (1) | AU6733690A (pt) |
| BG (1) | BG60068B2 (pt) |
| CA (1) | CA2030240A1 (pt) |
| DE (1) | DE69011318T2 (pt) |
| FI (1) | FI913478A0 (pt) |
| GB (1) | GB9024730D0 (pt) |
| HU (1) | HUT58334A (pt) |
| IE (1) | IE903911A1 (pt) |
| IL (1) | IL96407A0 (pt) |
| NZ (1) | NZ236127A (pt) |
| PT (1) | PT95929A (pt) |
| WO (1) | WO1991007404A1 (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE134624T1 (de) * | 1990-02-19 | 1996-03-15 | Ciba Geigy Ag | Acylverbindungen |
| GB9010394D0 (en) * | 1990-05-09 | 1990-06-27 | Ici Plc | Heterocyclic compounds |
| GB9025123D0 (en) * | 1990-11-19 | 1991-01-02 | Ici Plc | Nitrogen compounds |
| GB9102804D0 (en) * | 1991-02-11 | 1991-03-27 | Ici Plc | Heterocyclic derivatives |
| IL101860A0 (en) * | 1991-05-31 | 1992-12-30 | Ici Plc | Heterocyclic derivatives |
| JPH05213884A (ja) * | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
| US5246944A (en) * | 1991-08-13 | 1993-09-21 | Merck & Co., Inc. | Quinoline angiotensin ii antagonists incorporating a substituted benzyl element |
| GB9121727D0 (en) * | 1991-10-14 | 1991-11-27 | Ici Plc | Heterocyclic compounds |
| GB9202633D0 (en) * | 1992-02-07 | 1992-03-25 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
| TW297025B (pt) * | 1992-02-14 | 1997-02-01 | Squibb & Sons Inc | |
| GB2264710A (en) * | 1992-03-04 | 1993-09-08 | Merck & Co Inc | Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element |
| WO1993017682A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
| GB9211270D0 (en) * | 1992-05-28 | 1992-07-15 | Ici Plc | Nitrogen compounds |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| WO2003029210A2 (en) * | 2001-10-04 | 2003-04-10 | Merck & Co. Inc. | Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| AR037517A1 (es) * | 2001-11-05 | 2004-11-17 | Novartis Ag | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AR089929A1 (es) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | Proceso para manufacturar un derivado de naftiridina |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| EP3325623B3 (en) | 2015-07-23 | 2021-01-20 | Institut Curie | Use of a combination of dbait molecule and parp inhibitors to treat cancer |
| GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
| WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
| EP3765613A1 (en) | 2018-03-13 | 2021-01-20 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2023078252A1 (en) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| DE3907937A1 (de) * | 1989-03-11 | 1990-09-13 | Basf Ag | Substituierte 1,8-naphthylridine, verfahren zu ihrer herstellung und ihre verwendung als antidots |
| AU634561B2 (en) * | 1989-07-27 | 1993-02-25 | Eli Lilly And Company | Naphthyridine derivatives |
-
1990
- 1990-10-30 IE IE391190A patent/IE903911A1/en unknown
- 1990-11-14 GB GB909024730A patent/GB9024730D0/en active Pending
- 1990-11-19 AT AT91900302T patent/ATE109481T1/de not_active IP Right Cessation
- 1990-11-19 DE DE69011318T patent/DE69011318T2/de not_active Expired - Fee Related
- 1990-11-19 IL IL96407A patent/IL96407A0/xx unknown
- 1990-11-19 AU AU67336/90A patent/AU6733690A/en not_active Abandoned
- 1990-11-19 HU HU912485A patent/HUT58334A/hu unknown
- 1990-11-19 NZ NZ236127A patent/NZ236127A/en unknown
- 1990-11-19 JP JP2515806A patent/JPH04505161A/ja active Pending
- 1990-11-19 KR KR1019910700759A patent/KR920701206A/ko not_active Application Discontinuation
- 1990-11-19 WO PCT/GB1990/001776 patent/WO1991007404A1/en active IP Right Grant
- 1990-11-19 EP EP91900302A patent/EP0454831B1/en not_active Expired - Lifetime
- 1990-11-19 US US07/615,753 patent/US5126344A/en not_active Expired - Fee Related
- 1990-11-19 CA CA002030240A patent/CA2030240A1/en not_active Abandoned
- 1990-11-20 PT PT95929A patent/PT95929A/pt not_active Application Discontinuation
-
1991
- 1991-07-18 FI FI913478A patent/FI913478A0/fi unknown
- 1991-07-19 BG BG094862A patent/BG60068B2/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG60068B2 (bg) | 1993-09-30 |
| DE69011318D1 (de) | 1994-09-08 |
| GB9024730D0 (en) | 1991-01-02 |
| AU6733690A (en) | 1991-06-13 |
| JPH04505161A (ja) | 1992-09-10 |
| CA2030240A1 (en) | 1991-05-21 |
| KR920701206A (ko) | 1992-08-11 |
| PT95929A (pt) | 1991-09-13 |
| HUT58334A (en) | 1992-02-28 |
| NZ236127A (en) | 1993-08-26 |
| HU912485D0 (en) | 1991-12-30 |
| EP0454831A1 (en) | 1991-11-06 |
| WO1991007404A1 (en) | 1991-05-30 |
| DE69011318T2 (de) | 1994-12-01 |
| EP0454831B1 (en) | 1994-08-03 |
| FI913478A0 (fi) | 1991-07-18 |
| ATE109481T1 (de) | 1994-08-15 |
| US5126344A (en) | 1992-06-30 |
| IE903911A1 (en) | 1991-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL96407A0 (en) | Diazine derivatives | |
| CS161892A3 (en) | Heterocyclic derivatives, process of their preparation and pharmaceuticalcompositions in which said derivatives are comprised | |
| GB9113628D0 (en) | Heterocyclic derivatives | |
| NO902262D0 (no) | Fremgangsmaate for fremstilling av azainden-derivater. | |
| GR3017996T3 (en) | 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | |
| HU9403387D0 (en) | 7-(2-aminoethyl)-benzothiazolones | |
| HUT42770A (en) | Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same | |
| JO1648B1 (en) | Nitrogen compounds | |
| JO1697B1 (en) | Pyridine derivatives | |
| JO1720B1 (en) | Heterocyclic derivatives |